SBFMSunshine Biopharma, Inc.

$6M

Q3 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$16,800

Operating Income

-$113,805

Net Income

-$147,611

EPS (Diluted)

$-29522.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$148,188

Free Cash Flow

-$125,893

Stock-Based Comp.

$336,000

Balance Sheet

Total Assets

$256,000

Total Liabilities

$609,865

Stockholders' Equity

-$353,865

Cash & Equivalents

$188,086

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$16,800	-$9,483	-77.2%
Operating Income	-$113,805	-$116,016	+1.9%
Net Income	-$147,611	-$2M	+90.7%

SBFM Q3 2017 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena